Rose Research Center, LLC
Quick facts
Marketed products
Phase 3 pipeline
- Placebo zonisamide · Neurology
Zonisamide is an anticonvulsant that works by blocking voltage-sensitive sodium channels in the brain.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: